NCT03927430View on ClinicalTrials.gov

Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

March 1, 2019

Study Completion Date

March 1, 2019

Conditions
Epiretinal MembraneMacular HolesAge Related Macular Degeneration
Interventions
PROCEDURE

pars plana vitrectomy with membrane peeling

23-gauge pars plana vitrectomy with peeling of the epiretinal and internal limiting membrane as well as air- or gastamponade

Trial Locations (1)

09116

Klinikum Chemnitz, Ophthalmology Department, Chemnitz

All Listed Sponsors
lead

Klinikum Chemnitz gGmbH

OTHER

NCT03927430 - Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen | Biotech Hunter | Biotech Hunter